Modular system and process for the continuous, microbe-reduced production and/or processing of a product

Patent metadata

Field	Value
Publication number	US-10696940-B2
Application number	US-201615571754-A
Country	US
Kind code	B2
Filing date	Apr 29, 2016
Priority date	May 7, 2015
Publication date	Jun 30, 2020
Grant date	Jun 30, 2020

Abstract

The invention provides a method for the continuous, microbe-reduced production and/or processing of a biopharmaceutical, biological macromolecular product from a heterogeneous cell culture-fluid mixture, comprising the steps of: (a) providing a particle-free fluid from a heterogeneous cell culture-fluid mixture containing the product, in the form of a product stream, (b) at least one filtration, providing a filtrate, (c) at least two chromatography steps for purifying the product, (d) at least one virus depletion, (e) at least one ultrafiltration and/or at least one diafiltration of the product stream of steps (b), (c) and/or (d), characterized in that the at least two chromatography steps from (c) comprise a purification via at least two chromatography columns and/or membrane adsorbers in each case and that the process is carried out in a closed and modular manner The invention further provides a corresponding modular system for carrying out said method.

First claim

The invention claimed is:

1. A method for continuous, microbe-reduced production and/or processing of a biopharmaceutical, biological macromolecular product from a heterogeneous cell culture-fluid mixture, comprising:
(a) providing a particle-free fluid from a heterogeneous cell culture-fluid mixture containing the product, in the form of a product stream, (b) at least one filtration, providing a filtrate, (c) at least two chromatography steps for purifying the product, (d) at least one virus depletion selected from the group consisting of pH adjustment by way of suitable acid, use of a solvent and detergent treatment, and by UV or thermal treatment, (e) at least one ultrafiltration and/or at least one diafiltration of the product stream of (b), (c) and/or (d),
wherein the at least two chromatography steps from (c) comprise a purification via at least two chromatography columns and/or membrane adsorbers and wherein
the method is carried out in a closed and modular manner and is adapted to allow for addition of materials from outside the closed and modular manner,
wherein the product is not exposed to a room environment, and
wherein all elements used in (a) to (e) that come into contact with the product are subjected to microbe reduction via a microbe-reduction method, the microbe-reduction method being selected from the group consisting of gamma irradiation, beta irradiation, autoclaving, ethylene oxide (ETO) treatment, ozone (O 3 ) treatment, hydrogen peroxide (H 2 O 2 ) treatment and steam-in-place (SIP) treatment,
wherein at least one filtration step comprising at least one filter is carried out between a) to e) and/or thereafter,
and wherein the filter is automatically changed under microbe-reduced conditions, the automatic filter change comprising:
(i) switching of the flow path to a new filter in the event of exceeding of a threshold at a pressure sensor on the non-filtrate side with closing of the flow path, or in the event of exceeding of a maximum time of the used filter in the flow path, or in the event of exceeding of a maximum volume of filtrate through the used filter,
(ii) venting of the new filter via an air filter having a pore size of <=0.25 μm at the venting valve of the new filter,
(iii) detecting the completion of venting of the new filter on the non-filtrate side by means of the pressure sensor or a fill-level sensor or a balance or a liquid detector,
(iv) opening the filtrate outlet and closing the flow path between the venting valve and the air filter by means of a valve, and
(v) exchanging the used filter for a new filter.

Assignees

• Bayer Ag

Inventors

• Maiser Benjamin
• Schwan Peter
• Lobedann Martin
• Möhrle Volker

Classifications

• B01D61/243 Primary

  Dialysis · CPC title

• C12M47/16

  Sterilization (autoclaves in general B01J3/04) · CPC title

• C12M47/12 Primary

  Purification (C12M47/04 takes precedence) · CPC title

• C12M37/00

  Means for sterilizing, maintaining sterile conditions or avoiding chemical or biological contamination (C12M23/38 takes precedence; filtration in general and filters per se B01D24/00-B01D41/00; autoclaves B01J3/04; treatment of microorganisms with electrical or wave energy C12N13/00) · CPC title

• C07K16/00

  Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies · CPC title